REALE, Marcella
 Distribuzione geografica
Continente #
NA - Nord America 10.006
AS - Asia 7.169
EU - Europa 7.167
SA - Sud America 911
AF - Africa 93
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 7
Totale 25.374
Nazione #
US - Stati Uniti d'America 9.773
SG - Singapore 2.636
CN - Cina 2.543
IE - Irlanda 1.231
UA - Ucraina 1.177
IT - Italia 1.012
SE - Svezia 940
TR - Turchia 905
GB - Regno Unito 816
BR - Brasile 776
DE - Germania 595
FR - Francia 504
IN - India 371
VN - Vietnam 342
FI - Finlandia 290
RU - Federazione Russa 215
CA - Canada 158
CZ - Repubblica Ceca 72
HK - Hong Kong 66
AT - Austria 65
PL - Polonia 60
AR - Argentina 55
BD - Bangladesh 52
MX - Messico 48
KR - Corea 47
BE - Belgio 40
ES - Italia 40
JP - Giappone 37
NL - Olanda 33
ZA - Sudafrica 33
EC - Ecuador 26
ID - Indonesia 22
IQ - Iraq 22
EU - Europa 19
LT - Lituania 17
AE - Emirati Arabi Uniti 15
MA - Marocco 15
CL - Cile 12
PK - Pakistan 12
CO - Colombia 11
IL - Israele 11
IR - Iran 11
KE - Kenya 11
RO - Romania 11
EG - Egitto 10
UZ - Uzbekistan 8
PY - Paraguay 7
SA - Arabia Saudita 7
TN - Tunisia 7
VE - Venezuela 7
AL - Albania 6
AZ - Azerbaigian 6
BG - Bulgaria 6
BO - Bolivia 5
CH - Svizzera 5
HN - Honduras 5
HR - Croazia 5
NP - Nepal 5
PE - Perù 5
TH - Thailandia 5
AM - Armenia 4
AU - Australia 4
DO - Repubblica Dominicana 4
GR - Grecia 4
GT - Guatemala 4
JM - Giamaica 4
KZ - Kazakistan 4
PH - Filippine 4
PS - Palestinian Territory 4
RS - Serbia 4
TW - Taiwan 4
BN - Brunei Darussalam 3
CM - Camerun 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
HU - Ungheria 3
JO - Giordania 3
LB - Libano 3
MY - Malesia 3
NO - Norvegia 3
PA - Panama 3
PT - Portogallo 3
SR - Suriname 3
UY - Uruguay 3
BH - Bahrain 2
BW - Botswana 2
BY - Bielorussia 2
GE - Georgia 2
KG - Kirghizistan 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
Totale 25.357
Città #
Singapore 1.931
Chandler 1.402
Jacksonville 1.338
Dublin 1.224
Dallas 640
Beijing 579
Ashburn 534
Princeton 511
Southend 505
Izmir 464
Shenzhen 450
Nanjing 390
Los Angeles 288
The Dalles 274
Wilmington 266
Dearborn 258
Santa Clara 256
Chieti 235
Cambridge 222
Ann Arbor 193
New York 166
Munich 161
Altamura 158
Buffalo 142
Nanchang 140
Tongling 138
Boardman 133
Ho Chi Minh City 123
Woodbridge 123
São Paulo 98
Pescara 83
Shenyang 76
Council Bluffs 68
Redondo Beach 67
Hanoi 64
Hong Kong 63
Washington 63
Hebei 60
Tianjin 59
Grevenbroich 57
Houston 54
Jiaxing 54
Brooklyn 52
Kunming 50
Turku 50
Vienna 48
Montreal 43
Warsaw 43
Denver 42
Montréal 39
Dong Ket 38
Brno 37
Helsinki 37
Jinan 37
Tokyo 37
Toronto 37
Hefei 36
Brussels 35
Norwalk 35
Chennai 34
Hangzhou 34
Olomouc 33
Rome 33
Seoul 32
Changsha 29
London 29
Atlanta 28
Chicago 28
Falls Church 27
Seattle 27
Poplar 26
Frankfurt am Main 25
Amsterdam 23
Johannesburg 23
Phoenix 23
Stockholm 23
Mcallen 22
Ningbo 22
Boston 21
Milan 21
Zhengzhou 21
Guangzhou 20
San Francisco 20
Augusta 19
Orem 19
Rio de Janeiro 19
Orange 18
San Mateo 18
Auburn Hills 17
Pune 17
Ankara 16
Brasília 16
Düsseldorf 16
Scottsdale 16
Manchester 15
Belo Horizonte 14
Mexico City 13
Nuremberg 13
Taizhou 13
Changchun 12
Totale 15.701
Nome #
Neuronal cellular responses to extremely low frequency electromagnetic field exposure: implications regarding oxidative stress and neurodegeneration 546
Mast cell recruitment after subcutaneous injection of RANTES in the sole of the rat paw. 237
Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties 182
Antiinflammatory effects in THP-1 cells treated with verbascoside 160
Blood natural killer activity is reduced in men with occupational stress and job insecurity working in a university 158
Effects of 50 Hz sinusoidal electromagnetic fields on MCP-1 and RANTES generated from activated human macrophages 158
Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation 156
Cholinergic Markers and Cytokines in OSA Patients 152
Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1β levels and expression in peripheral blood mononuclear cells 151
Effect of probiotic supplement on cytokine levels in HIV-infected individuals: A preliminary study 149
Dysregulated homeostasis of acetylcholine levels in immune cells of RR-multiple sclerosis patients 149
5-HT and histamine release from rat basophilic leukemia cells treated or non with IL-1RA 149
Follow up study on the immune response to low frequency electromagnetic fields in men and women working in a museum. 145
Augmentation of monocyte chemotactic protein-1 (MCP-1) and mRNA Transcript in chronic inflammatory states induced by potassium permanganate (KMnO4) in vivo 145
Work stress and innate immune response 144
Activity of matrix metallo proteinases (MMPs) and the tissue inhibitorof MMP (TIMP)-1 in electromagnetic field-exposed THP-1 cells. 143
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 142
NSAID Coniugates for the treatment of Alzheimer's Disease 141
Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1beta and interleukin-6 release from lymphocytes of Alzheimer's disease patients 140
Extremely low frequency electromagnetic field enhances human keratinocyte cell growth and decreases proinflammatory chemokine production 140
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 140
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 139
Cholinergic System Dysfunction in Multiple Sclerosis Patients 139
Antiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights and Diagnostic Challenges 137
Effect of occupational stress and anxiety on natural killer lymphocyte activity of men and women employed in a university. 134
Age-related Expression of Cholinergic Markers and Cytokines in the Olfactory Bulb of a Rat Model of Alzheimer’s Disease. 133
Synergistic activation of serum amyloid a (saa) by il - 6 and il - 1 in combination on human hep 3 b hepatoma cell line. Role of pge2 and il-1 receptor antagonist 132
Anti-inflammatory properties of acetylcholinesterase inhibitors administred in Alzheimer's disease 131
Extremely low-frequency electromagnetic fields accelerates wound healing modulating MMP-9 and inflammatory cytokines 131
Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related 130
Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer’s Disease: present and future applications 129
Oxygen supply modulates MCP-1 release in monocytes from young and aged rats: decrease of MCP-1 transcription and translation is age-related 128
Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls. 128
EMF Exposure Facilitates Wound Healing Events Modulating Cytokines Expression. 126
Interferon β1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis 126
The immune response of women with prolonged exposure to electromagnetic fields produced by radiotelevision broadcasting stations. 125
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease 125
Critical review on the presence of phthalates in food and evidence of their biological impact 125
"In vitro" effects of different arsenic compounds on PBMC (preliminary study). 124
Effect of electromagnetic fields on several CD markers and transcription and expression of CD4 123
Monocyte chemotactic protein 1 (MCP-1) activates mast cells to aggregate and release [3H]-5HT 122
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 122
Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents 122
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 120
In vitro effects of nickel-sulphate on immune functions of normal and nickel-allergic subjects: a regulatory role for zinc. 120
MicroRNA in Sjögren's syndrome: Their potential roles in pathogenesis and diagnosis 120
Well-being at work and immune response 120
Increased expression of transforming growth factor beta isoforms by human monocytes of hypertensive patients 118
In vitro effects of vanadate on human immune functions 117
Very low electromagnetic field and innate immunity in HaCaT cells 115
Th17 cytokines from pathogenesis to therapeutic strategies in chronic plaque psoriasis 115
Extremely Low Frequency Electromagnetic Field and Cytokines Production. 115
Alzheimer's Disease and Type 2 Diabetes Mellitus: The Link to Tyrosine Hydroxylase and Probable Nutritional Strategies 115
Profiling of canonical and non-traditional cytokine levels in IFNbeta-treated RR-MS patients 115
Relationship between inflammatory mediators, Aβ levels and ApoE genotype in Alzheimer disease 115
Effects of palladium nanoparticles on the cytokine release from peripheral blood mononuclear cells of palladium-sensitized women 115
Acetylcholine in multiple sclerosis: possible involvement in the modulation of the immune response and in oligodendrocyte recruitment. 114
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 114
Monocyte Chemotactis Protein-1 Gene Expression and Translation in Formed Granulomatous Calcified Tissue in Vivo 114
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 114
Production of cytokines in trichinellosis infected mice 113
Mitochondria as an easy target to oxidative stress events in Parkinson's disease 113
L-carnitine enhances adenosine triphosphate (ATP) and inhibits lymphocite proliferation 113
Cytokine Levels and UVr Sensitivity in HaCaT Cells and Cetuximab Treated Patients. 113
Anti-inflammatory strategy: Old ally or new promise in therapy 113
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 113
Cytokines and T cells in atopic dermatitis. 112
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect? 112
A pathophysiological role for selective alteration of the cytokine-chemokine network - inflammatory theory in Alzheimer's disease 112
The down-regulation of il-6-stimulated fibrinogen steadu state mrna and protein levels by human recombinant il-1 is not pge2-dependent:effects of il-1 receptor antagonist (il-1ra) 111
Heat shock protein 70: implication for Alzheimer's disease 111
Massive infiltration of basophilic cells in inflamed tissue after injection of RANTES. 110
Modulation of MCP-1 and iNOS by 50 Hz sinusoidal electromagnetic field 110
Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-β ex vivo activation of peripheral chemo-cytokines from Alzheimer's disease subjects: exploring the cholinergic anti-inflammatory pathway 110
In vitro effects of low frequency electromagnetic fields on Anti Microbial Peptides (AMP) expression 109
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 108
Alzheimer’s Disease And Type 2 Diabetes: Exploring The Association To Obesity And Tyrosine Hydroxylase 108
Circulating Adipokine Levels in Mild Psoriatic Patients 108
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b 107
Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. 107
Inhibitory effects of cadmium on peripheral blood mononuclear cell proliferation and cytokine release are reversed by zinc and selenium salts 107
SERUM HMW ADIPONECTIN, RBP-4, VISFATIN, APELIN AND HMGB1 LEVELS IN MILD PSORIATIC PATIENTS 107
Anti-cancer effects of polyphenols via targeting p53 signaling pathway: updates and future directions 107
Effect of interleukin-1 receptor antagonist (IL-1RA) on histamine and serotonin release by rat basophilic leukemia cells (RBL-2H3) and peritoneal mast cells 106
Human Gingival Fibroblasts Exposed to Extremely Low-Frequency Electromagnetic Fields: In Vitro Model of Wound-Healing Improvement 106
Assessment of the Vanillin Anti-Inflammatory and Regenerative Potentials in Inflamed Primary Human Gingival Fibroblast 106
Human recombinant interleukin-1 receptor antagonist (hrIL-1RA) inhibits prostaglandin E2(PGE) generation but not alkaline phosphatase activity in in vivo chronic granulomatous tissue induced by KMnO4 104
Down regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. 104
Aumentati livelli mucosali gastrici di IL-1alfa, IL-6 ed IL-8 in pazienti Helicobacter pylori-positivi affetti da cardiopatia ischemica. 104
Job strain in different types of employment affects the immune response 104
Different effects of platinum, palladium, and rhodium salts on lymphocyte proliferation and cytokine release 104
Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology 104
Effect of environmental extremely low-frequency electromagnetic fields exposure on inflammatory mediators and serotonin metabolism in a human neuroblastoma cell line. 103
Lipids at the Cross-Road of Autoimmunity in Multiple Sclerosis 103
In Vitro Wound-Healing Properties of Water-Soluble Terpenoids Loaded on Halloysite Clay 103
Monocyte chemoattractant protein-1 as a mitogen for vascular smooth muscle cell 102
Chemokine secretion by mononuclear cells of patients with multiple sclerosis (MS) 102
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 102
Modulation of interleukin 18 by treatment with acetylcholinesterase inhibition in Alzheimer patients 102
Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increase 3H-thymidine incorporation and the release of 3H arachidonic acid in human macrophages 102
Totale 12.729
Categoria #
all - tutte 105.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.020 0 0 0 0 0 338 26 27 200 200 86 143
2021/20221.176 62 14 14 222 72 32 43 93 88 34 134 368
2022/20233.810 296 454 220 447 379 771 227 300 487 63 96 70
2023/20242.282 104 68 582 60 110 518 477 62 18 31 29 223
2024/20254.794 319 855 802 96 131 167 131 233 485 220 585 770
2025/20264.821 801 472 1.107 1.168 915 358 0 0 0 0 0 0
Totale 26.501